Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Cambridge, UK, March 24, 2026 (GLOBE NEWSWIRE) -- The first solution that uses an understanding of each individual’s behavior to integrate email security controls with personalized security...
-
ATLANTA, March 24, 2026 (GLOBE NEWSWIRE) -- Bitcoin Depot (NASDAQ: BTM) (“Bitcoin Depot” or the “Company”), a U.S.-based Bitcoin ATM operator and fintech company, today announced that Scott Buchanan...
-
ZenaTech Developing an Integrated Counter-UAS System Pairing the Interceptor P-1 Low-Cost Drone with Zena AI Detection and Swarm Command Software
-
Miata Intersects 96 m of 1.41 g/t gold in Near-Surface Gold System at Big Berg, Delivering Best Intercept to Date at the Sela Creek Gold Project, Suriname
-
Launched VIZZ® (aceclidine ophthalmic solution) 1.44% for the treatment of presbyopia in October 2025 and generated net product revenues of $1.6 million in the first quarter of launch On pace for...
-
BERKELEY, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Deep Isolation Nuclear, Inc. (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today announced the...
-
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, March 24, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage...
-
VANCOUVER, Wash. and NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with...
-
LOS ANGELES, March 24, 2026 (GLOBE NEWSWIRE) -- Pacvue, a leader in AI-powered commerce and retail media technology, and Market Performance Group (MPG), a leading omnichannel commerce agency...
-
Callio Therapeutics is actively developing a pipeline of promising dual-payload ADCs featuring rationally designed payload combinations for hard-to-treat tumors CLIO-8221 is the first program from...